[Marchiafava-Micheli syndrome and pregnancy].

PubWeight™: 0.75‹?›

🔗 View Article (PMID 3443716)

Published in J Gynecol Obstet Biol Reprod (Paris) on January 01, 1987

Authors

H Fernandez1, J C Pons, P Solal-Celigny, G Tertian, G Tchernia, E Papiernik

Author Affiliations

1: Service de Gynécologie Obstétrique, Hôpital A. Béclère, Clamart, Université Paris-Sud.

Articles by these authors

Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d'Etude des Lymphomes de l'Adulte. J Clin Oncol (2005) 7.03

The gene encoding ribosomal protein S19 is mutated in Diamond-Blackfan anaemia. Nat Genet (1999) 6.23

Association of pregnancy-induced hypertension with duration of sexual cohabitation before conception. Lancet (1994) 5.78

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis. Cancer (1981) 4.25

Epidemiology of preterm birth. Epidemiol Rev (1993) 3.79

Occurrence of myeloproliferative disorder in patients with Noonan syndrome. J Pediatr (1997) 3.14

Myelodysplastic syndromes in childhood: report of 49 patients from a French multicentre study. French Society of Paediatric Haematology and Immunology. Br J Haematol (1996) 2.69

Antenatal glucocorticoid treatment and cystic periventricular leukomalacia in very premature infants. N Engl J Med (1999) 2.33

Deficiency of skeletal membrane protein band 4.1 in homozygous hereditary elliptocytosis. Implications for erythrocyte membrane stability. J Clin Invest (1981) 2.27

European phase II study of rituximab (chimeric anti-CD20 monoclonal antibody) for patients with newly diagnosed mantle-cell lymphoma and previously treated mantle-cell lymphoma, immunocytoma, and small B-cell lymphocytic lymphoma. J Clin Oncol (2000) 2.19

Identification of new prognosis factors from the clinical and epidemiologic analysis of a registry of 229 Diamond-Blackfan anemia patients. DBA group of Société d'Hématologie et d'Immunologie Pédiatrique (SHIP), Gesellshaft für Pädiatrische Onkologie und Hämatologie (GPOH), and the European Society for Pediatric Hematology and Immunology (ESPHI). Pediatr Res (1999) 2.16

Fetal platelet counts in thrombocytopenic pregnancy. Lancet (1990) 2.13

Antenatal thrombocytopenia in three patients with TAR (thrombocytopenia with absent radii) syndrome. Prenat Diagn (1993) 2.11

Mutations in ribosomal protein S19 gene and diamond blackfan anemia: wide variations in phenotypic expression. Blood (1999) 2.07

Long-term in vitro culture of murine mast cells. I. Description of a growth factor-dependent culture technique. J Immunol (1981) 1.99

Fetal karyotype from cystic hygroma fluid. Prenat Diagn (1992) 1.92

Prevention of preterm births: a perinatal study in Haguenau, France. Pediatrics (1985) 1.78

Risk factors for ectopic pregnancy: a case-control study in France, with special focus on infectious factors. Am J Epidemiol (1991) 1.76

Long-term in vitro culture of murine mast cells. II. Purification of a mast cell growth factor and its dissociation from TCGF. J Immunol (1981) 1.71

Level and causes of maternal mortality in Guinea (West Africa). Int J Gynaecol Obstet (1992) 1.68

Multifactorial study of the risk of prematurity at 32 weeks of gestation. I. A study of the frequency of 30 predictive characteristics. J Perinat Med (1974) 1.60

Development after exposure to mifepristone in early pregnancy. Lancet (1991) 1.59

Mifepristone teratogenicity. Lancet (1991) 1.58

Working conditions, maternity legislation, and preterm birth. Semin Perinatol (1995) 1.51

What are the fetal growth patterns of singletons, twins, and triplets in the United States? Clin Obstet Gynecol (1998) 1.51

Hemolysis and schistocytosis in the emergency department: consider pseudothrombotic microangiopathy related to vitamin B12 deficiency. QJM (2013) 1.50

Long-term evaluation of the beneficial effect of subtotal splenectomy for management of hereditary spherocytosis. Blood (2001) 1.48

Restoration of normal membrane stability to unstable protein 4.1-deficient erythrocyte membranes by incorporation of purified protein 4.1. J Clin Invest (1986) 1.47

Spurious monosomy 7 in leukemia due to centromeric heteromorphism. Cancer Genet Cytogenet (2000) 1.45

Hypospadias in sons of women exposed to diethylstilbestrol in utero. Prenat Diagn (2005) 1.45

Employment, working conditions, and preterm birth: results from the Europop case-control survey. J Epidemiol Community Health (2004) 1.44

Trends in twin birth outcomes and prenatal care utilization in the United States, 1981-1997. JAMA (2000) 1.43

A randomized trial of amsacrine and rubidazone in 39 patients with acute promyelocytic leukemia. J Clin Oncol (1991) 1.42

Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature review. Ann Oncol (2003) 1.40

Antenatal parvovirus infection: clinical implications. Pediatr Hematol Oncol (1998) 1.39

On twin care: early detection of twin pregnancies with the use of charts of normal uterine height and waist measurements. Prog Clin Biol Res (1978) 1.39

[Sports and pregnancy. A review of the literature]. J Gynecol Obstet Biol Reprod (Paris) (1990) 1.38

Secular trend in the rate of small-for-gestational-age infants: Haguenau Study 1971-1985. Br J Obstet Gynaecol (1988) 1.38

[Role of endocervical curettage in the screening for cervical cancer: apropos of a series of 31 cases]. Gynecol Obstet Fertil (2000) 1.37

Lymphoid interstitial pneumonitis in acquired immunodeficiency syndrome-related complex. Am Rev Respir Dis (1985) 1.32

Low-dose cytarabine versus intensive chemotherapy in the treatment of acute nonlymphocytic leukemia in the elderly. J Clin Oncol (1990) 1.30

Chronic myelomonocytic leukemia according to FAB classification: analysis of 35 cases. Blood (1984) 1.29

Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients. Br J Dermatol (2013) 1.27

Doxorubicin-containing regimen with or without interferon alfa-2b for advanced follicular lymphomas: final analysis of survival and toxicity in the Groupe d'Etude des Lymphomes Folliculaires 86 Trial. J Clin Oncol (1998) 1.26

Loss of attachment to fibronectin with terminal human erythroid differentiation. Blood (1990) 1.26

Tumor necrosis factor alpha release is a major biological event associated with rituximab treatment. Hematol J (2001) 1.20

Molecular basis of hereditary elliptocytosis due to protein 4.1 deficiency. N Engl J Med (1986) 1.19

The relationship between intrauterine growth restriction and preterm delivery: an empirical approach using data from a European case-control study. BJOG (2000) 1.18

Frequency of immune thrombocytopenia in newborns: a prospective study. Immune Thrombocytopenia Working Group. Blood (1997) 1.17

Meta-analysis to evaluate the role of interferon in follicular lymphoma. J Clin Oncol (2005) 1.17

IL-2 mRNA expression in Tac-positive malignant lymphomas. Am J Pathol (1990) 1.17

Preterm birth prevention: an evaluation of programs in the United States. Birth (1991) 1.16

An isoform-specific mutation in the protein 4.1 gene results in hereditary elliptocytosis and complete deficiency of protein 4.1 in erythrocytes but not in nonerythroid cells. J Clin Invest (1993) 1.15

HIV-associated endometritis. AIDS (1989) 1.14

The number of polymorphonuclear leukocytes in relation to gestational age in the newborn. Acta Paediatr Scand (1979) 1.13

Primary hematopoietic cells from DBA patients with mutations in RPL11 and RPS19 genes exhibit distinct erythroid phenotype in vitro. Cell Death Dis (2012) 1.12

Evidence for linkage of familial Diamond-Blackfan anemia to chromosome 8p23.3-p22 and for non-19q non-8p disease. Blood (2001) 1.12

Diamond-Blackfan anemia. Curr Opin Pediatr (2001) 1.11

Rates of very preterm birth in Europe and neonatal mortality rates. Arch Dis Child Fetal Neonatal Ed (2008) 1.10

Fatal post-splenectomy pneumococcal sepsis despite pneumococcal vaccine and penicillin prophylaxis. Lancet (1984) 1.09

The association between occupational factors and preterm birth: a United States nurses' study. Research Committee of the Association of Women's Health, Obstetric, and Neonatal Nurses. Am J Obstet Gynecol (1995) 1.09

Very and moderate preterm births: are the risk factors different? Br J Obstet Gynaecol (1999) 1.07

Obstetric interventions for babies born before 28 weeks of gestation in Europe: results of the MOSAIC study. BJOG (2009) 1.07

Role of the Plasmodium falciparum mature-parasite-infected erythrocyte surface antigen (MESA/PfEMP-2) in malarial infection of erythrocytes. Blood (1995) 1.06

Are risk factors the same for small for gestational age versus other preterm births? Am J Obstet Gynecol (2001) 1.06

Influence of routine administration of folic acid and iron during pregnancy. Gynecol Obstet Invest (1981) 1.05

Lineage- and stage-specific adhesion of human hematopoietic progenitor cells to extracellular matrices from marrow fibroblasts. Blood (1988) 1.05

Suppressor cell function after intravenous gammaglobulin treatment in adult chronic idiopathic thrombocytopenic purpura. Br J Haematol (1985) 1.05

Chorionic villus sampling after first trimester diagnosis of fetal cystic hygroma colli. Eur J Obstet Gynecol Reprod Biol (1989) 1.04

Glycophorin C content of human erythrocyte membrane is regulated by protein 4.1. Blood (1990) 1.04

Multicentred controlled trial of cervical cerclage in women at moderate risk of preterm delivery. Br J Obstet Gynaecol (1984) 1.03

18F-fluorodeoxyglucose-positron emission tomography before, during and after treatment in mature T/NK lymphomas: a study from the GOELAMS group. Ann Oncol (2010) 1.03

Androgens and progestins in the human ovarian follicle: differences in the evolution of preovulatory, healthy nonovulatory, and atretic follicles. J Clin Endocrinol Metab (1981) 1.03

Immune disorders in agnogenic myeloid metaplasia: relations to myelofibrosis. Br J Haematol (1983) 1.02

Treatment of homozygous protein C deficiency and neonatal purpura fulminans with a purified protein C concentrate. N Engl J Med (1991) 1.02

Expression of the bcl-2 gene product in follicular lymphoma. Am J Pathol (1992) 1.02

Oral magnesium supplements reduce erythrocyte dehydration in patients with sickle cell disease. J Clin Invest (1997) 1.02

Radiation myositis: the possible role of gemcitabine. Ann Oncol (2000) 1.02

Temporal differences in membrane loss lead to distinct reticulocyte features in hereditary spherocytosis and in immune hemolytic anemia. Blood (2001) 1.02

Natural history of hereditary spherocytosis during the first year of life. Blood (2000) 1.01

Preterm birth and maternal country of birth in a French district with a multiethnic population. BJOG (2004) 1.01

Diamond-Blackfan anaemia: genetic homogeneity for a gene on chromosome 19q13 restricted to 1.8 Mb. Nat Genet (1997) 1.01

[Proteinuria and loaiasis. Histologic, optic and electronic study of a case]. Bull Mem Soc Med Hop Paris (1967) 1.00

[1st instance of the absence of an erythrocyte membrane protein (band 4(1)) in a case of familial elliptocytic anemia]. Nouv Rev Fr Hematol (1980) 1.00

Red cell abnormalities in hereditary spherocytosis: relevance to diagnosis and understanding of the variable expression of clinical severity. J Lab Clin Med (1996) 1.00

Human reticulocyte maturation and its relevance to erythropoietic stress. J Lab Clin Med (1979) 1.00

Fetal and neonatal alloimmune thrombocytopenia: current trends in diagnosis and therapy. Transfus Med (1992) 0.99

Obstetric patients treated in intensive care units and maternal mortality. Regional Teams for the Survey. Eur J Obstet Gynecol Reprod Biol (1996) 0.98

Multifocal deficits due to leukemic meningoradiculitis in chronic lymphocytic leukemia. J Neurol Sci (2008) 0.97

The persistence of a high maternal mortality rate in the Ivory Coast. Am J Public Health (1996) 0.97

Frequency of very late fatal sepsis after splenectomy for hereditary spherocytosis: impact of insufficient antibody response to pneumococcal infection. Ann Hematol (1999) 0.97

The costs of multiple pregnancy. Int J Gynaecol Obstet (1991) 0.96